GENEVA, July 9 -- NOVO NORDISK A/S filed a patent application (EP2026/050911) for “SEMAGLUTIDE IN MEDICAL THERAPY INCLUDING WEIGHT MANAGEMENT”. With publication no. WO/2026/078277, here are the other details related to the patent application:
Kind: Later publication of international search report [A3]
IPC: A61K 38/26
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....